Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy
Go back to Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy| AMERICAN RCT REIT (NASDAQ: ARCT) | Delayed: 14.69 -1.34 (8.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.03 | 52 Week High | $13.09 | |||
| Open | $16.37 | 52 Week Low | $5.54 | |||
| Day High | $16.55 | P/E | N/A | |||
| Day Low | $14.60 | EPS | $-0.38 | |||
| Volume | 1,001,491 | |||||
